Anke C Schiedel Selected Research

Ocular Albinism

1/2017	Interaction between G Protein-Coupled Receptor 143 and Tyrosinase: Implications for Understanding Ocular Albinism Type 1.
1/2017	Identification of Novel G Protein-Coupled Receptor 143 Ligands as Pharmacologic Tools for Investigating X-Linked Ocular Albinism.
1/2017	Author Response: Comment on "Identification of Novel G Protein-Coupled Receptor 143 Ligands as Pharmacologic Tools for Investigating X-Linked Ocular Albinism".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anke C Schiedel Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 05/2009
4	Astrocytoma (Pilocytic Astrocytoma) 02/2017 - 02/2008
3	Ocular Albinism 01/2017 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2018
2	Pain (Aches) 02/2017 - 08/2011
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Parkinson Disease (Parkinson's Disease) 08/2021
1	COVID-19 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Ocular Albinism type 1 01/2017
1	Inflammation (Inflammations) 01/2013
1	Seizures (Absence Seizure) 09/2011
1	Asthma (Bronchial Asthma) 08/2011
1	Heart Diseases (Heart Disease) 05/2009
1	Parasitic Diseases (Parasitic Disease) 05/2009
1	Virus Diseases (Viral Diseases) 05/2009
1	Neuroblastoma 02/2008
1	Glioma (Gliomas) 02/2008
1	Cross Infection (Nosocomial Infection) 09/2007

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 05/2009
4	Adenine FDA LinkGeneric 09/2013 - 09/2007
3	LigandsIBA 01/2022 - 01/2017
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 01/2017
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2013 - 10/2009
1	Biological ProductsIBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	FilaminsIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Early Growth Response Protein 1IBA 01/2020
1	Caffeine (No Doz)FDA LinkGeneric 03/2018
1	Ion Channels (Ion Channel)IBA 02/2017
1	Adenosine Triphosphate (ATP)IBA 02/2017
1	NucleotidesIBA 02/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Rhodopsin (Visual Purple)IBA 09/2013
1	Dithiothreitol (Cleland's Reagent)IBA 09/2013
1	DisulfidesIBA 09/2013
1	Adenosine (Adenocard)FDA LinkGeneric 01/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2011
1	Adenosine A2B ReceptorIBA 08/2011
1	NucleosidesIBA 05/2009
1	Messenger RNA (mRNA)IBA 02/2008
1	2-fluoroadenineIBA 02/2008
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2008

Therapy/Procedure

3	Therapeutics 08/2021 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2020